201 related articles for article (PubMed ID: 35880406)
1. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
[TBL] [Abstract][Full Text] [Related]
2. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
[TBL] [Abstract][Full Text] [Related]
3. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
5. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
Yang Y; Ju H; Huang Y
Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
[TBL] [Abstract][Full Text] [Related]
7. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
[TBL] [Abstract][Full Text] [Related]
9. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
[TBL] [Abstract][Full Text] [Related]
10. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
11. Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.
Wu M; Zhang M; Cao J; Wu S; Chen Y; Luo L; Lin X; Su M; Zhang X
Arch Gynecol Obstet; 2023 Aug; 308(2):631-637. PubMed ID: 35994107
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of American College of Radiology Ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
Wang R; Yang Z
Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
[TBL] [Abstract][Full Text] [Related]
14. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
Shi Y; Li H; Wu X; Li X; Yang M
J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
Zhang Q; Dai X; Li W
AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
[No Abstract] [Full Text] [Related]
16. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
[TBL] [Abstract][Full Text] [Related]
17. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology.
Gong LP; Li XY; Wu YN; Dong S; Zhang S; Feng YN; Lv YE; Guo XJ; Peng YQ; Du XS; Tian JW; Sun CX; Sun LT
J Ovarian Res; 2023 Mar; 16(1):57. PubMed ID: 36945000
[TBL] [Abstract][Full Text] [Related]
18. External Validation of O-RADS US Risk Stratification and Management System.
Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
